The Effect of Repeated Low-Level Red-Light Therapy on Myopia Control and Choroid
Translational Vision Science & Technology · 2024
DOI: 10.1167/tvst.13.10.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2024. Verfasst von Ying Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Choroid, Myopia, Axial Length, Eye, Tomography, Optical Coherence. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To investigate the long-term effects of repeated low-level red light (RLRL) therapy on the axial length (AL), spherical equivalent (SE), and choroidal parameters.
Methods
Two hundred eight myopic eyes were recruited. The RLRL group included 100 eyes, whereas the control group included 108 eyes. Throughout the one-year follow-up period, changes in AL and SE were recorded for both groups. The RLRL group underwent additional choroidal imaging, and changes in choroidal thickness (CT), choroidal vascularity (CV), and choriocapillaris luminal area (CLA) were assessed before and after RLRL therapy.
Results
During the follow-up period, the changing trends in AL and SE differed significantly between the RLRL and control groups. In the RLRL group, AL decreased at three and six months (both P < 0.05) and returned to pretreatment values at 12 months (P = 0.453). In contrast, AL increased significantly throughout the follow-up period (three, six, and 12 months) in the control group (all P < 0.001). The SE increased significantly during the entire follow-up period in the RLRL group (all P < 0.001), whereas it decreased significantly in the control group (all P < 0.05). Regarding choroidal parameters, significant improvements were observed in CT, CV and CLA throughout the follow-up period (all P < 0.05), and changes in most choroidal parameters were significantly correlated with changes in AL and SE during the follow-up period (all P < 0.05). Furthermore, AL, SE, and most choroidal parameters showed significant correlations between changes at three and 12 months (all P < 0.05).
Conclusions
RLRL therapy significantly improved choroidal blood perfusion and circulation, which may explain the observed slowing or reversal of myopia progression in the RLRL group. Thus RLRL therapy may be a novel and effective method for controlling myopia. Furthermore, the short-term effect of photobiomodulation therapy (i.e., changes at three months) can be used to predict the long-term effects (i.e., changes at 12 months). Translational Relevance: In this study, RLRL therapy showed a significant control effect on the development of axial length and spherical equivalent. RLRL therapy also promoted the choroidal blood perfusion and circulation. RLRL therapy could be a novel and effective method for myopia control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Ophthalmology, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zitieren
APA
Liu, Y., Zhu, M., Yan, X., Li, M., & Xiang, Y. (2024). The Effect of Repeated Low-Level Red-Light Therapy on Myopia Control and Choroid. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.13.10.29
Vancouver
Liu Y, Zhu M, Yan X, Li M, Xiang Y. The Effect of Repeated Low-Level Red-Light Therapy on Myopia Control and Choroid. Translational Vision Science & Technology. 2024. doi:10.1167/tvst.13.10.29
BibTeX
@article{Liu2024,
author = {Liu, Ying and Zhu, Mengxia and Yan, Xiaoqin and Li, Mu and Xiang, Yan},
title = {The Effect of Repeated Low-Level Red-Light Therapy on Myopia Control and Choroid},
journal = {Translational Vision Science & Technology},
year = {2024},
doi = {10.1167/tvst.13.10.29}
}
EUVIMED